Navigation Links
CoreTherm™ Microwave Thermotherapy System

ProductsCoreTherm™ Microwave Thermotherapy System
Company GYRUS ACMI
Item CoreTherm™ Microwave Thermotherapy System
Features 
  • Intraprostatic temperature monitoring > Temperature monitoring at the point of prostatic tissue ablation
  • Calculated cell-kill > Unique real-time modeling of prostatic cell-kill
  • Intraprostatic blood flow index > Microwave power can be adjusted to account for the variability in each individual patient's intraprostatic blood flow.
Description The CoreTherm Microwave Thermotherapy System is the Next Generation thermotherapy device for the treatment of symptomatic BPH. Other thermotherapy systems treat patients on standard treatment protocols, discounting the effect of each patient's individual intraprostatic blood flow characteristics will have on achieving the desired therapeutic temperatures and therefore, the treatment outcome.The CoreTherm System employs a patented intraprostatic temperature probe that measures actual tissue temperatures at three locations within the prostate. This data is used by the PLFT Software to provide the treating physician the following data:
Real time measurement of temperatures achieved in the prostate.
The dynamic changes in the intraprostatic blood flow during the treatment.
An estimate of tissue destruction by providing real-time Calculated Cell Kill from the actual temperatures achieved and the duration of the treatment.
Info GYRUS ACMI
Customer Service: (508) 804-2600
Web site: http://www.acmicorp.com

Related medicine products :

1. AquaTherm Water-Induced Thermotherapy (WIT) System
2. TherMatrx® Dose Optimized Thermotherapy™
3. Silicone Oil Cannula System - 20 Gauge
4. Silicone Oil Cannula System - 19 Gauge
5. SuperVu Galilean System
6. KOWA nonmyd 7 / VK-2 Digital Imaging System
7. KOWA nonmyd a-D / VK-2 Digital Imaging System
8. Refraction System RT-2100
9. Odyssey Phacoemulsification System
10. SIStem Phacoemulsification System
11. Precisionist Phacoemulsification System
Mumps IgG ELISA....
Toxo IgG ELISA. All Wampole ELISA kits include the following: 12 x 8 well strips with breakaway wells, sample diluent, controls and calibrators, conjugate, TMB substrate, wash buffer, stop solution,...
Herpes Simplex Virus 2 IgG ELISA....
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Medicine Products:
(Date:7/25/2017)... ... July 25, 2017 , ... ... announced it will be exhibiting and providing demos of its smart journaling platform ... Washington Convention Center in Washington D.C. from August 3-6, 2017. , The APA ...
(Date:7/25/2017)... Jacksonville, Fla. (PRWEB) , ... July 25, 2017 , ... ... employee and father Ezra Clark is taking advantage of a new benefit for employees ... “It really means a lot that the company supports me and other employees as ...
(Date:7/24/2017)... Florida (PRWEB) , ... July ... ... Division Marketing Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & ... joined together to celebrate the structural topping out of the new Destination ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum in ... take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland Rockside ... a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is sponsored ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
Breaking Medicine Technology: